Abstract
Is There a Role for Low Doses of Mitotane (o,p′,DDD) as Adjuvant Therapy in Adrenocortical Carcinoma?—Authors’ Response
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have